Capvaxive Injection, Solution
Product Images NDC 0006-4347

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Capvaxive (NDC 0006-4347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe carton)

Packaging label for CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine injection, solution, intended for intramuscular use. The label includes a single 0.5 mL syringe dose containing a total of 84 mcg pneumococcal polysaccharide antigen conjugated to approximately 65 mcg CRM197 carrier protein. Labeler is Merck Sharp & Dohme LLC. The label advises refrigeration and notes use for individuals 18 years and older.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe carton)

Packaging label for CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine injection, solution. This label is for 10 single-dose 0.5 mL syringes intended for intramuscular use. The product is labeled for refrigeration and is manufactured by Merck Sharp & Dohme LLC. The NDC on the label is 0006-4347-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.